The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity
Open accessAbstract
Objective: To develop simple, practical criteria for clinical diagnosis of fibromyalgia that are suitable for use in primary and specialty care and that do not require a tender point examination, and to provide a severity scale for characteristic fibromyalgia symptoms. Methods: We performed a multicenter study of 829 previously diagnosed fibromyalgia patients and controls using physician physical and interview examinations, including a widespread pain index (WPI), a measure of the number of painful body regions. Random forest and recursive partitioning analyses were used to guide the development of a case definition of fibromyalgia, to develop criteria, and to construct a symptom severity (SS) scale. Results: Approximately 25% of fibromyalgia patients did not satisfy the American College of Rheumatology (ACR) 1990 classification criteria at the time of the study. The most important diagnostic variables were WPI and categorical scales for cognitive symptoms, unrefreshed sleep, fatigue, and number of somatic symptoms. The categorical scales were summed to create an SS scale. We combined the SS scale and the WPI to recommend a new case definition of fibromyalgia: (WPI ≥7 AND SS ≥5) OR (WPI 3–6 AND SS ≥9). Conclusion: This simple clinical case definition of fibromyalgia correctly classifies 88.1% of cases classified by the ACR classification criteria, and does not require a physical or tender point examination. The SS scale enables assessment of fibromyalgia symptom severity in persons with current or previous fibromyalgia, and in those to whom the criteria have not been applied. It will be especially useful in the longitudinal evaluation of patients with marked symptom variability.
Verified 2026-10-22 · 1 reference not checked yet
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
3 of 14 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Fatigue, cognitive symptoms, and the extent of somatic symptoms became increasingly known and appreciated as key fibromyalgia features.
“the importance of symptoms that had not been considered by the ACR Multicenter Criteria Committee became increasingly known and appreciated as key fibromyalgia features: for example, fatigue, cognitive symptoms, and the extent of somatic symptoms (4 -7).”
Quote in the paperSubstantial claim2 of 4 sources checked- cites [4] 4. Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford L, Glass JM, et al, for the OMERACT Fibromyalgia Working Group. Fibromyalgia syndrome module at OMERACT 9: domain con- struct. J Rheumatol 2009;36:2318 -29. source
The Introduction (page not provided) says the 1990 ACR criteria focused on widespread pain and tenderness, while patients also experience fatigue, cognitive dysfunction, and other symptoms. The Cognition section calls dyscognition a salient symptom. The paper does not identify the extent of somatic symptoms as a key feature in the same way, so that part of the claim is not supported. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [5] 5. Choy EH, Arnold LM, Clauw DJ, Crofford LJ, Simon LS, Mar- tin SA, et al. Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol 2009;36:2330 -4. source
The Introduction (page unavailable) lists fatigue and dyscognition (cognitive dysfunction) among the relevant fibromyalgia domains identified through earlier patient and clinician exercises. It does not identify the extent of somatic symptoms as a domain or establish the claimed progression in recognition of all three features. The Discussion (page unavailable) also says clinical-trial data were insufficient to require dyscognition in the core dataset. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [6] 6. Mease P. Fibromyalgia syndrome: review of clinical presen- tation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005;75:6 -21.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [7] 7. Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Car- ville S, et al. Fibromyalgia syndrome. J Rheumatol 2007;34: 1415-25.
- Findingown data
Approximately 25% of patients considered to have fibromyalgia by their physicians did not satisfy the ACR 1990 classification criteria at the time of the study.
“Approximately 25% of fibromyalgia patients did not satisfy the American College of Rheumatology (ACR) 1990 classification criteria at the time of the study.”
- Also stated in: § Characteristics of patients by fibromyalgia status. · plain
“Taken as a whole, these data show that approximately 25% of patients considered to have fibromyalgia by their physicians do not satisfy ACR classification criteria for fibromyalgia”
Quote in the paperSubstantial claim- Rests on an assumption: The ACR 1990 classification criteria are a valid reference standard for identifying fibromyalgia cases.
- Also stated in: § Characteristics of patients by fibromyalgia status. · plain
- Findingown data
The new case definition (WPI >7 AND SS >5) OR (WPI 3-6 AND SS >9) correctly classifies 88.1% of cases classified by the ACR classification criteria.
“This simple clinical case definition of fibromyalgia correctly classifies 88.1% of cases classified by the ACR classification criteria”
Quote in the paperSubstantial claim- Rests on an assumption: The ACR 1990 classification criteria are a valid reference standard for identifying fibromyalgia cases.
- Findingown data
The most important diagnostic variables for fibromyalgia were the WPI and categorical scales for cognitive symptoms, unrefreshed sleep, fatigue, and number of somatic symptoms.
“The most important diagnostic variables were WPI and categorical scales for cognitive symptoms, unrefreshed sleep, fatigue, and number of somatic symptoms.”
Quote in the paperSubstantial claim- Rests on an assumption: Physician diagnosis of fibromyalgia is a valid way to identify fibromyalgia patients for the study.
- Findingown data
Removing all muscle variables and the WPI resulted in a misclassification rate of 16.1%.
“Removing all of the muscle variables and the WPI resulted in a misclassification rate of 16.1% (Table 2).”
Quote in the paperSubstantial claim
- Findingown data
Using the short variable list, the misclassification rate was 18.4%.
“Using the short variable list (that never contains muscle pain or muscle weakness), the misclassification rate was 18.4%.”
Quote in the paperSubstantial claim - Findingown data
Physician study variables misclassified fibromyalgia cases and controls at rates of 6.2-10.3%, depending on the number of variables in the model and whether the WPI was continuous or categorical.
“Depending on the number of variables in the model (variable group) and whether the WPI was used as a continuous or a categorical variable, physician study variables misclassified fibromyalgia cases and controls at rates of 6.2-10.3%(Table 2).”
Quote in the paperSubstantial claim - Findingown data
For count of patient-endorsed somatic symptoms, physician somatic symptom scale, and SS scale, prior fibromyalgia patients had scores somewhat closer to current fibromyalgia patients than to control subjects.
“However, for the count of patient-endorsed somatic symptoms, the physician somatic symptom scale, and the SS scale, prior fibromyalgia patients had scores that were somewhat closer to current fibromyalgia patients than to control subjects.”
Quote in the paperNot a substantial claim - Findingown data
Patients previously diagnosed by clinical criteria were more likely to be classified as prior fibromyalgia (38.3%) compared with patients previously diagnosed by the ACR classification criteria (18.9%; P<0.001).
“Patients previously diagnosed by clinical criteria were more likely to be classified as prior fibromyalgia (38.3%) compared with patients previously diagnosed by the ACR classification criteria (18.9%;P Ͻ 0.001).”
Quote in the paperNot a substantial claim- Rests on an assumption: The ACR 1990 classification criteria are a valid reference standard for identifying fibromyalgia cases.
- Findingown data
The WPI and muscle tenderness were the most important variables in the classification of cases and noncases.
“Figure 2A shows that the WPI and muscle tenderness were the most important variables in the classification of cases and noncases.”
Quote in the paperNot a substantial claim - Findingown data
These variables are strongly correlated with the tender point count and the WPI.
“As shown in Table 3, these variables are strongly correlated with the tender point count and the WPI.”
Quote in the paperSubstantial claim - Findingown data
Six categorical rating scale variables had high importance levels: somatic symptoms, waking unrefreshed, cognition, fatigue, sleep problems, and mood.
“From Figure 2B, we identified 6 categorical rating scale variables that had high importance levels (somatic symptoms, waking unrefreshed, cognition, fatigue, sleep problems, and mood).”
Quote in the paperSubstantial claim - Findingown data
Pain intensity was less strongly correlated with the tender point count and WPI (correlation coefficients 0.346 and 0.437, respectively) than the six categorical variables.
“For comparison, pain intensity, with correlation coefficients of 0.346 and 0.437, respectively, was less strongly correlated.”
Quote in the paperSubstantial claim - Findingown data
Irritable bowel syndrome, abdominal pain, and headache added no power to correct classification.
“However, they added no power to correct classification and we did not include them in the diagnostic criteria.”
Quote in the paperSubstantial claim - Findingown data
When applied to study patients using the ACR classification criteria definition of fibromyalgia, the mean SS scale score for prior fibromyalgia was 6.0 ± 2.6.
“When applied to study patients, using the ACR classifi- cation criteria definition of fibromyalgia, the mean Ϯ SD SS scale score for fibromyalgia was 8.0 Ϯ 2.6, for prior fibromyalgia was 6.0 Ϯ 2.6, and for controls was 3.3 Ϯ 2.2 (Table 1).”
Quote in the paperNot a substantial claim - Findingown data
Although not a study requirement for enrollment, all of the patients with fibromyalgia diagnosed by physicians had symptoms for at least 3 months.
“Although not a study requirement for enrollment, all of the patients with fibromyalgia diagnosed by physicians had symptoms for at least 3 months.”
Quote in the paperNot a substantial claim - Findingown data
A 5-component SS scale that included mood did not perform as well as a 4-component scale.
“In addition, as shown in Table 3, a 5-component SS scale that included mood did not perform as well as a 4-component scale.”
Quote in the paperSubstantial claim - Findingown data
Using the recommended definition, 9.1% of controls would be diagnosed as having fibromyalgia.
“Using this definition, 9.1% of controls would be diagnosed as having fibromyalgia, 53.1% of prior fibromyalgia patients would be diagnosed as having fibromyalgia, and 14.1% of ACR classification criteria-positive cases would not be diagnosed as having fibromyalgia.”
Quote in the paperSubstantial claim - Findingnone given
When applied to the ACR classification criteria, correct classification falls to 79.2%.
“When applied to the ACR classification criteria, correct classification falls to 79.2%.”
Quote in the paperSubstantial claim - Findingown data
Mood was correlated with somatic symptoms at 0.621.
“Although we omitted mood, it was correlated with the SS scale at 0.725 and with the components of the SS scale as follows: cognition 0.625, somatic symptoms 0.621, waking unrefreshed 0.619, and fatigue 0.612.”
Quote in the paperNot a substantial claim - Findingown data
Of the 315 patients categorized, 42.2% had current fibromyalgia.
“We categorized the 315 patients into 3 groups based on prior diagnosis and current ACR classification criteria status: 42.2% with current fibromyalgia, 13.3% with prior fibromyalgia, and 44.4% who were neither current nor prior fibromyalgia patients.”
Quote in the paperNot a substantial claim - Findingown data
Unrefreshed sleep was a better measure than sleep disturbance.
“Unrefreshed sleep was a better measure than sleep disturbance and we recommend its use in the SS scale.”
Quote in the paperSubstantial claim - Findingown data
Mood was correlated with waking unrefreshed at 0.619.
“Although we omitted mood, it was correlated with the SS scale at 0.725 and with the components of the SS scale as follows: cognition 0.625, somatic symptoms 0.621, waking unrefreshed 0.619, and fatigue 0.612.”
Quote in the paperNot a substantial claim - Findingown data
96.3% of the patients in the study satisfying the diagnostic criteria had 3 or more tender points.
“However, 98.7% of the patients in the study satisfying the diagnostic criteria had a least 1 tender point and 96.3% had 3 or more tender points.”
Quote in the paperNot a substantial claim - Findingown data
Using the ACR classification criteria as the gold standard, the diagnostic criteria diagnose 82.6% of cases correctly.
“using the ACR classification criteria as the gold standard, the diagnostic criteria diagnose 82.6% of cases correctly compared with the clinician's correct diagnosis rate of 84.1%.”
Quote in the paperSubstantial claim - Findingown data
Of the binary variables, irritable bowel syndrome, abdominal pain, and headache had variable importance.
“Of the binary variables, irritable bowel syndrome, abdominal pain, and headache had variable importance.”
Quote in the paperNot a substantial claim - Findingreasoning
The WPI best identified patients diagnosed with the ACR classification criteria.
“The WPI, which strongly correlated with the tender point count and the SS scale, best identified patients diagnosed with the ACR classification criteria.”
Quote in the paperSubstantial claim - Findingown data
Mood was correlated with fatigue at 0.612.
“Although we omitted mood, it was correlated with the SS scale at 0.725 and with the components of the SS scale as follows: cognition 0.625, somatic symptoms 0.621, waking unrefreshed 0.619, and fatigue 0.612.”
Quote in the paperNot a substantial claim - Findingreasoning
Patient data did not work as well in correct classification as physician data.
“Although we collected data directly from patients as well as data from physicians, patient data did not work as well in correct classification as physician data (Table 2).”
Quote in the paperNot a substantial claim - Findingown data
Mood was correlated with cognition at 0.625.
“Although we omitted mood, it was correlated with the SS scale at 0.725 and with the components of the SS scale as follows: cognition 0.625, somatic symptoms 0.621, waking unrefreshed 0.619, and fatigue 0.612.”
Quote in the paperNot a substantial claim - Findingown data
Results in Table 2 showed little gain from the complete data sets.
“Based on the results in Table 2, which showed little gain from the complete data sets, we collapsed the questionnaire to categorical scales and changed the format to a form that could be used in the clinic.”
Quote in the paperSubstantial claim - Findingown data
When applied to study patients using the ACR classification criteria definition of fibromyalgia, the mean SS scale score for fibromyalgia was 8.0 ± 2.6.
“When applied to study patients, using the ACR classifi- cation criteria definition of fibromyalgia, the mean Ϯ SD SS scale score for fibromyalgia was 8.0 Ϯ 2.6, for prior fibromyalgia was 6.0 Ϯ 2.6, and for controls was 3.3 Ϯ 2.2 (Table 1).”
Quote in the paperNot a substantial claim - Findingown data
Using the SS scale score cutoff of ≥7, the mean score for non-fibromyalgia was 2.8 ± 1.4.
“Using the SS scale score cutoff of Ն7, the mean Ϯ SD respective scores were 8.6 Ϯ 1.8 and 2.8 Ϯ 1.4.”
Quote in the paperNot a substantial claim - Findingown data
98.7% of the patients in the study satisfying the diagnostic criteria had at least 1 tender point.
“However, 98.7% of the patients in the study satisfying the diagnostic criteria had a least 1 tender point and 96.3% had 3 or more tender points.”
Quote in the paperNot a substantial claim - Findingown data
Overall, the fibromyalgia rate among all study subjects would increase from 38.1% to 45.5% using the recommended definition.
“Overall, the fibromyalgia rate among all of the study subjects would increase from 38.1% to 45.5% using the recommended definition.”
Quote in the paperNot a substantial claim - Findingown data
The SS scale was strongly correlated with the WPI (0.733).
“The SS scale was strongly correlated with the WPI (0.733) and the tender point count (0.680), and was the strongest correlate of WPI after the tender point count, which was correlated with the WPI at 0.773 (Table 3).”
Quote in the paperSubstantial claim - Findingown data
Using the recommended definition, 14.1% of ACR classification criteria-positive cases would not be diagnosed as having fibromyalgia.
“Using this definition, 9.1% of controls would be diagnosed as having fibromyalgia, 53.1% of prior fibromyalgia patients would be diagnosed as having fibromyalgia, and 14.1% of ACR classification criteria-positive cases would not be diagnosed as having fibromyalgia.”
Quote in the paperSubstantial claim - Findingown data
The SS scale was strongly correlated with the tender point count (0.680).
“The SS scale was strongly correlated with the WPI (0.733) and the tender point count (0.680), and was the strongest correlate of WPI after the tender point count, which was correlated with the WPI at 0.773 (Table 3).”
Quote in the paperSubstantial claim - Findingown data
Using the newly proposed categorical definition for fibromyalgia, the mean SS scale score for non-fibromyalgia was 2.9 ± 1.6.
“Using the newly proposed categorical definition for fibromyalgia, the mean Ϯ SD SS scale score for fibromyalgia was 8.5 Ϯ 2.0, and for non-fibromyalgia was 2.9 Ϯ 1.6.”
Quote in the paperNot a substantial claim - Findingown data
The distribution of SS scale scores defines the 3 diagnostic categories.
“As shown in Figure 3, the distribution of SS scale scores defines the 3 diagnostic categories and provides measurement of fibromyalgia symptom severity to patients who do and do not currently satisfy ACR fibromyalgia criteria.”
Quote in the paperSubstantial claim - Findingown data
In sensitivity analyses, unrefreshed sleep provided marginally better differentiating power.
“However, in sensitivity analyses, it provided marginally better differentiating power; we suggest that either scale can be used, although unrefreshed sleep is better.”
Quote in the paperNot a substantial claim - Findingown data
In developing new diagnostic criteria, the authors identified 2 variables that best defined fibromyalgia and its symptom spectrum: the WPI and the composite SS scale.
“In developing new diagnostic criteria, we identified 2 variables that best defined fibromyalgia and its symptom spectrum: the WPI and the composite SS scale.”
Quote in the paperSubstantial claim- Rests on an assumption: The case definition of fibromyalgia has changed somewhat with increasing recognition of the importance of cognitive problems and somatic symptoms, factors that were not even considered in the 1990 ACR classification criteria.
- Findingown data
When applied to study patients using the ACR classification criteria definition of fibromyalgia, the mean SS scale score for controls was 3.3 ± 2.2.
“When applied to study patients, using the ACR classifi- cation criteria definition of fibromyalgia, the mean Ϯ SD SS scale score for fibromyalgia was 8.0 Ϯ 2.6, for prior fibromyalgia was 6.0 Ϯ 2.6, and for controls was 3.3 Ϯ 2.2 (Table 1).”
Quote in the paperNot a substantial claim - Findingown data
Using the recommended definition, 53.1% of prior fibromyalgia patients would be diagnosed as having fibromyalgia.
“Using this definition, 9.1% of controls would be diagnosed as having fibromyalgia, 53.1% of prior fibromyalgia patients would be diagnosed as having fibromyalgia, and 14.1% of ACR classification criteria-positive cases would not be diagnosed as having fibromyalgia.”
Quote in the paperSubstantial claim - Findingown data
Using the newly proposed categorical definition for fibromyalgia, the mean SS scale score for fibromyalgia was 8.5 ± 2.0.
“Using the newly proposed categorical definition for fibromyalgia, the mean Ϯ SD SS scale score for fibromyalgia was 8.5 Ϯ 2.0, and for non-fibromyalgia was 2.9 Ϯ 1.6.”
Quote in the paperNot a substantial claim - Findingown data
The tender point count was correlated with the WPI at 0.773.
“The SS scale was strongly correlated with the WPI (0.733) and the tender point count (0.680), and was the strongest correlate of WPI after the tender point count, which was correlated with the WPI at 0.773 (Table 3).”
Quote in the paperNot a substantial claim - Findingown data
Approximately 25% of diagnosed fibromyalgia patients in both phases of the study did not satisfy the ACR classification criteria, although they were considered to have fibromyalgia by their physicians.
“One of the important findings of the current study was that approximately 25% of diagnosed fibromyalgia patients in both phases of the study did not satisfy the ACR classification criteria, although they were considered to have fibromyalgia by their physicians.”
Quote in the paperSubstantial claim - Findingown data
A severity score ≥7 correctly classifies 92.3% of cases identified by the new diagnostic criteria definition: (WPI ≥7 AND SS ≥5) OR (WPI 3-6 AND SS ≥9).
“A severity score Ն7 correctly classifies 92.3% of cases identified by the new diagnostic criteria definition: (WPI Ն7 AND SS Ն5) OR (WPI 3-6 AND SS Ն9).”
Quote in the paperSubstantial claim - Findingown data
Using the SS scale score cutoff of ≥7, the mean score for fibromyalgia was 8.6 ± 1.8.
“Using the SS scale score cutoff of Ն7, the mean Ϯ SD respective scores were 8.6 Ϯ 1.8 and 2.8 Ϯ 1.4.”
Quote in the paperNot a substantial claim - Findingown data
In phase 2, the ACR classification criteria were used in 74.6% of fibromyalgia diagnoses.
“The ACR classification criteria were used in 74.6% of fibromyalgia diagnoses.”
Quote in the paperNot a substantial claim - Findingown data
The clinician's correct diagnosis rate was 84.1%.
“using the ACR classification criteria as the gold standard, the diagnostic criteria diagnose 82.6% of cases correctly compared with the clinician's correct diagnosis rate of 84.1%.”
Quote in the paperNot a substantial claim - Findingown data
This simple clinical case definition of fibromyalgia correctly classifies 88.1% of cases classified by the ACR classification criteria.
“This simple clinical case definition of fibromyalgia correctly classifies 88.1% of cases classified by the ACR classification criteria, and does not require a physical or tender point examination.”
Quote in the paperSubstantial claim - Findingnone given
This simple clinical case definition of fibromyalgia does not require a physical or tender point examination.
“This simple clinical case definition of fibromyalgia correctly classifies 88.1% of cases classified by the ACR classification criteria, and does not require a physical or tender point examination.”
Quote in the paperSubstantial claim - Findingown data
A symptom severity scale score >6 identifies patients satisfying the new diagnostic criteria in 92.3% of cases.
“A symptom severity scale score Ͼ6 identifies patients satisfying the new diagnostic criteria in 92.3% of cases.”
Quote in the paperSubstantial claim - Findingreasoning
The best misclassification rate obtainable with patient data was 12.7% compared with 6.2% with physician data.
“The best misclassification rate obtainable with patient data was 12.7% compared with 6.2% with physician data.”
Quote in the paperNot a substantial claim - Interpretationown data
The new case definition does not require a physical or tender point examination.
“and does not require a physical or tender point examination”
Quote in the paperSubstantial claim - Interpretationreasoning
The SS scale enables assessment of fibromyalgia symptom severity in persons with current or previous fibromyalgia, and in those to whom the criteria have not been applied.
“The SS scale enables assessment of fibromyalgia symptom severity in persons with current or previous fibromyalgia, and in those to whom the criteria have not been applied.”
- Also stated in: § DISCUSSION · plain
“The SS scale enables assessment of fibromyalgia symptom severity in persons with current or previous fibromyalgia, and in those to whom the criteria have not been applied.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · plain
- Study design and conductown data
The proportion of patients who were controls or had prior or current fibromyalgia did not differ between expert physicians and clinical rheumatologists (P=0.640).
“The proportion of patients who were controls or had prior or current fibromyalgia did not differ between the group of 10 expert physicians and the 20 clinical rheumatologists (P ϭ 0.640).”
Quote in the paperNot a substantial claim - Premisereasoning
Patients who improved or whose symptoms and tender points decreased could fail to satisfy the ACR 1990 classification definition.
“Patients who improved or whose symptoms and tender points decreased could fail to satisfy the ACR 1990 classification definition.”
Quote in the paperSubstantial claim - Interpretationown data
Patients considered to have fibromyalgia by their physicians who did not satisfy ACR criteria appear to have an intermediate severity position between fibromyalgia patients and control subjects, except for somatic symptoms.
“Taken as a whole, these data show that approximately 25% of patients considered to have fibromyalgia by their physicians do not satisfy ACR classification criteria for fibromyalgia, and that they appear to have an intermediate severity position between fibromyalgia patients and control subjects, except for somatic symptoms.”
Quote in the paperSubstantial claim- Rests on an assumption: The ACR 1990 classification criteria are a valid reference standard for identifying fibromyalgia cases.
- Rests on an assumption: Physician diagnosis of fibromyalgia is a valid way to identify fibromyalgia patients for the study.
- Interpretationown data
Misclassification rates obtainable under optimum data mining conditions that do not contain ACR classification criteria-related variables are between 16.1% and 18.4% (14.0% if muscle pain is allowed).
“These data show that misclassification rates obtainable under optimum data mining conditions that do not contain ACR classification criteria-related variables are between 16.1% and 18.4% (14.0% if muscle pain is allowed).”
Quote in the paperSubstantial claim - Interpretationreasoning
The distribution of SS scale scores provides measurement of fibromyalgia symptom severity to patients who do and do not currently satisfy ACR fibromyalgia criteria.
“As shown in Figure 3, the distribution of SS scale scores defines the 3 diagnostic categories and provides measurement of fibromyalgia symptom severity to patients who do and do not currently satisfy ACR fibromyalgia criteria.”
Quote in the paperSubstantial claim - Interpretationown data
Results from phase 2 in Table 5 suggest that the criteria would work satisfactorily in the final format.
“Results from phase 2 in Table 5 suggest that the criteria would work satisfactorily in the final format, which is included in Table 4.”
Quote in the paperSubstantial claim - Interpretationreasoning
Loss of a tender point or a painful region for any reason, including improvement, can result in failing to meet classification or diagnostic criteria.
“The loss of a tender point or a painful region for any reason, including improvement, can result in failing to meet classification or diagnostic criteria.”
Quote in the paperSubstantial claim - Interpretationreasoning
Neither the ACR classification criteria nor the diagnostic criteria suggested here provide a solution for the classification dilemma of patients who have fibromyalgia but do not meet criteria.
“Neither the ACR classification criteria nor the diagnostic criteria suggested here provide a solution for this classification dilemma.”
Quote in the paperSubstantial claim- Rests on an assumption: The central problem in fibromyalgia criteria is the absence of a gold standard or case definition.
- Interpretationreasoning
Fibromyalgia diagnosis is based on severity assessments.
“It arises because fibromyalgia diagnosis is based on severity assessments.”
Quote in the paperSubstantial claim - Interpretationreasoning
The suggested diagnostic criteria create a small discordance between the older ACR classification criteria case definition and the current definition proposed.
“The suggested diagnostic criteria create a small discordance between the older ACR classification criteria case definition and the current definition that we have proposed.”
Quote in the paperNot a substantial claim - Interpretationown data
The SS scale was the strongest correlate of WPI after the tender point count.
“The SS scale was strongly correlated with the WPI (0.733) and the tender point count (0.680), and was the strongest correlate of WPI after the tender point count, which was correlated with the WPI at 0.773 (Table 3).”
Quote in the paperNot a substantial claim - Study design and conductown data
The study did not study the performance of these criteria in primary care.
“Although our goal was to develop simple, practical criteria for clinical diagnosis of fibromyalgia that are suitable for use in primary and specialty care, we did not study the performance of these criteria in primary care.”
Quote in the paperSubstantial claim - Interpretationreasoning
The difference in classification performance between patient and physician data is related to the fact that it is the physician and not the patient who makes the diagnosis.
“This difference is related to the fact that it is the physician and not the patient who makes the diagnosis.”
Quote in the paperNot a substantial claim - Study design and conductown data
The study did not test the criteria among those with other rheumatic conditions.
“We also did not test the criteria among those with other rheumatic conditions, and we recommend that this be done in the future, too.”
Quote in the paperSubstantial claim
- May combine two claims. 30
- Classified as probably not a substantial claim. 11
- The quote only partly states this claim. 1
May combine two claims.
PremisecitationSubsequent studies as well as the data of this study showed the importance of quantitative measures of body pain and of the key variables that comprise the SS scale in characterizing fibromyalgia.
“Subsequent studies as well as the data of this study showed the importance of (improved) quantitative measures of body pain (18 -22), and of the key variables that comprise the SS scale in characterizing fibromyalgia.”
Quote in the paperSubstantial claim1 of 5 sources checked- cites [18] 18. Macfarlane GJ. Chronic widespread pain and fibromyalgia: should reports of increased mortality influence management? Curr Rheumatol Rep 2005;7:339 -41.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [19] 19. Moldofsky H. The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes. Joint Bone Spine 2008;75:397-402.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [20] 20. Hieblinger R, Coenen M, Stucki G, Winkelmann A, Cieza A. Validation of the International Classification of Functioning, Disability and Health core set for chronic widespread pain from the perspective of fibromyalgia patients. Arthritis Res Ther 2009;11:R67. source
The Discussion (page not available in our copy) says pain was the central topic reported by fibromyalgia patients, with 159 concepts linked to sensation of pain. That supports the importance of pain, but this qualitative focus-group study does not establish the importance of improved quantitative measures of body pain—the part to which this citation is attached. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [21] 21. Macfarlane GJ, Jones GT, Knekt P, Aromaa A, McBeth J, Mikkelsson M, et al. Is the report of widespread body pain associated with long-term increased mortality? Data from the Mini-Finland Health Survey. Rheumatology (Oxford) 2007; 46:805-7. source
- cites [22] 22. Macfarlane GJ, Pye SR, Finn JD, Wu FC, Silman AJ, Bartfai G, et al. Investigating the determinants of international differ- ences in the prevalence of chronic widespread pain: evidence from the European Male Ageing Study. Ann Rheum Dis 2009; 68:690 -5. source
May combine two claims.
Findingown dataPrior and current fibromyalgia patients had similar distributions of somatic symptom counts, while prior fibromyalgia had the WPI shifted somewhat to the left.
“Prior and current fibromyalgia patients had similar distributions of somatic symptom counts (Figure 1B), while prior fibromyalgia had the WPI shifted somewhat to the left (Figure 1A).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWhen all patients were considered, WPI >=7 performed about as well (83.6%) as physician diagnosis (84.1%) in the classification of fibromyalgia in phase 1, with improvement in phase 2.
“When all of the patients were considered, WPI Ն7 performed about as well (83.6%) as physician diagnosis (84.1%) in the classification of fibromyalgia in phase 1, again with improvement in the phase 2 data.”
Quote in the paperSubstantial claim- Rests on an assumption: The ACR 1990 classification criteria are a valid reference standard for identifying fibromyalgia cases.
- Rests on an assumption: Physician diagnosis of fibromyalgia is a valid way to identify fibromyalgia patients for the study.
May combine two claims.
Findingown dataThe tender point count demonstrated the clearest distinction between groups, followed by unrefreshed sleep.
“The tender point count (Figure 1D) demonstrates the clearest distinction between groups, followed by unrefreshed sleep (Figure 1C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the comparison of ACR classification criteria-positive versus ACR classification criteria-negative cases (excluding prior fibromyalgia), the correct classification rates for phase 1 ran between 89.0% and 92.6%, with higher rates in phase 2.
“In addition, in the comparison of ACR classification criteria-positive versus ACR classification criteria-negative cases (excluding prior fibromyalgia), the correct classification rates for phase 1 ran between 89.0% and 92.6%, with higher rates being obtained in phase 2 analyses.”
Quote in the paperSubstantial claim- Rests on an assumption: The ACR 1990 classification criteria are a valid reference standard for identifying fibromyalgia cases.
May combine two claims.
Findingown dataACR classification criteria were used in 63.6% of fibromyalgia diagnoses and clinical diagnosis was used in 36.4% of fibromyalgia diagnoses.
“ACR classification criteria were used in 63.6% of fibromyalgia diagnoses and clinical diagnosis was used in 36.4% of fibromyalgia diagnoses.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataValues of the WPI >=7 best identified fibromyalgia cases and values <=6 best identified control cases according to their ACR classification criteria status.
“We then applied recursive partitioning to the data and determined that values of the WPI Ն7 best identified fibromyalgia cases and values Յ6 best identified control cases according to their ACR classification criteria status.”
Quote in the paperSubstantial claim- Rests on an assumption: The ACR 1990 classification criteria are a valid reference standard for identifying fibromyalgia cases.
May combine two claims.
Findingown dataThere was a clear difference in clinical findings and symptom severity among groups, with current fibromyalgia patients having the greatest symptom severity and prior fibromyalgia generally at the midpoint between current fibromyalgia and controls.
“There was a clear difference in clinical findings and symptom severity among the groups, the current fibromyalgia patients having the greatest symptom severity with prior fibromyalgia generally occupying the severity scale midpoint between current fibromyalgia and controls (Table 1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataKeeping muscle pain in the intermediate model reduced the error rate to 14.0%, whereas removing the WPI but leaving all muscle pain and muscle tenderness variables resulted in a misclassification rate of 10.3%.
“Using the same intermediate model but keeping muscle pain reduced the error rate to 14.0%, whereas removing the WPI but leaving all muscle pain and muscle tenderness variables resulted in a misclassification rate of 10.3%.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt the time of the study examination, 74.5% of patients previously diagnosed with fibromyalgia satisfied the ACR classification criteria and 2.0% of controls satisfied the ACR classification criteria.
“At the time of the study examination, 74.5% of patients who had been previously diagnosed with fibromyalgia satisfied the ACR classification criteria and 2.0% of controls satisfied the ACR classification criteria.”
Quote in the paperSubstantial claim- Rests on an assumption: The ACR 1990 classification criteria are a valid reference standard for identifying fibromyalgia cases.
May combine two claims.
Findingown dataAmong patients diagnosed as having fibromyalgia, 76.0% met ACR classification criteria compared with 74.5% in the first phase of the study.
“Among patients diagnosed as having fibromyalgia, 76.0% met ACR classification criteria compared with 74.5% in the first phase of the study.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe WPI strongly correlated with the tender point count and the SS scale.
“The WPI, which strongly correlated with the tender point count and the SS scale, best identified patients diagnosed with the ACR classification criteria.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOf the 315 patients categorized, 13.3% had prior fibromyalgia.
“We categorized the 315 patients into 3 groups based on prior diagnosis and current ACR classification criteria status: 42.2% with current fibromyalgia, 13.3% with prior fibromyalgia, and 44.4% who were neither current nor prior fibromyalgia patients.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAlthough mood was omitted, it was correlated with the SS scale at 0.725.
“Although we omitted mood, it was correlated with the SS scale at 0.725 and with the components of the SS scale as follows: cognition 0.625, somatic symptoms 0.621, waking unrefreshed 0.619, and fatigue 0.612.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataCriteria to identify ACR classification criteria cases worked slightly better in phase 2.
“The validation sample was slightly different in the 2 phases (Figure 3), and criteria to identify ACR classification criteria cases worked slightly better in phase 2.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOf the 315 patients categorized, 44.4% were neither current nor prior fibromyalgia patients.
“We categorized the 315 patients into 3 groups based on prior diagnosis and current ACR classification criteria status: 42.2% with current fibromyalgia, 13.3% with prior fibromyalgia, and 44.4% who were neither current nor prior fibromyalgia patients.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPhysician diagnosis only correctly classified 84.1% of cases, while the proposed diagnostic criteria, even with shift of definition, identified 82.6% of patients correctly.
“In addition, it should be remembered that physician diagnosis only correctly classified 84.1% of cases, while the proposed diagnostic criteria, even with shift of definition, identified 82.6% of patients correctly (Table 5).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe validation sample was slightly different in the 2 phases.
“The validation sample was slightly different in the 2 phases (Figure 3), and criteria to identify ACR classification criteria cases worked slightly better in phase 2.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataMissing data were rare: in phase 1, 81.7% of patients had no missing data, 12.8% had 1 missing data point, and 1.6% had 3-8 missing data points.
“Missing data were rare: in phase 1, 81.7% of patients had no missing data, 12.8% had 1 missing data point, and 1.6% had 3-8 missing data points.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe ACR 1990 classification criteria required tenderness on pressure in at least 11 of 18 specified sites and the presence of widespread pain for diagnosis.
“The criteria required tenderness on pressure (tender points) in at least 11 of 18 specified sites and the presence of widespread pain for diagnosis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1] 1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33: 160 -72. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe study was approved by the Via Christi Institutional Review Board.
“The study was approved by the Via Christi Institutional Review Board.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductnone givenThe criteria set has been quantitatively validated using patient data, but has not undergone validation based on an external data set.
“This signifies that the criteria set has been quantitatively validated using patient data, but it has not undergone validation based on an external data set.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Premisenone givenThe ACR classification criteria set such a high bar for diagnosis that there was little variation in symptoms among fibromyalgia patients.
“the ACR classification criteria set such a high bar for diagnosis that there was little variation in symptoms among fibromyalgia patients”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe tender point count was rarely performed in primary care where most fibromyalgia diagnoses occurred, and when performed, was performed incorrectly.
“the tender point count was rarely performed in primary care where most fibromyalgia diagnoses occurred, and when performed, was performed incorrectly (2)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] 2. Fitzcharles MA, Boulos P. Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology (Oxford) 2003;42:263-7. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims. The quote only partly states this claim.
Study design and conductown dataIn phase 1, 610 patients were enrolled from 32 referring physicians; 96 (15.7%) were excluded for protocol violations, leaving 514 subjects.
“In phase 1, we enrolled 610 patients from 32 referring physicians between December 2, 2008, and April 30, 2009.We excluded 96 patients (15.7%) for one or more protocol violations.”
- Also stated in: § SUBJECTS AND METHODS · plain
“After exclusions, there were 514 subjects (mean 17 and median 20 per center).”
Quote in the paperNot a substantial claim- Also stated in: § SUBJECTS AND METHODS · plain
May combine two claims.
PremisecitationMany physicians did not know how to examine for tender points and some simply refused to do so.
“Many physicians did not know how to examine for tender points and some simply refused to do so (3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] 3. Buskila D, Neumann L, Sibirski D, Shvartzman P. Awareness of diagnostic and clinical features of fibromyalgia among fam- ily physicians. Fam Pract 1997;14:238 -41. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataExamining physicians were compensated $2,000 for their work; the study authors received no compensation.
“Examining physicians were each compensated $2,000 for their work in interviewing, examining, and completing study forms for 10 patients and 10 controls.The study authors received no compensation.”
- Also stated in: § Abstract · plain
“The authors received no compensation.”
Quote in the paperNot a substantial claim- Also stated in: § Abstract · plain
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataFibromyalgia subjects were slightly older than controls (mean 54.6 vs 52.3 years; P=0.035), but did not differ by percentage of males, non-Hispanic whites, or education level.
“Fibromyalgia subjects were slightly older than controls (mean Ϯ SD age 54.6 Ϯ 12.9 versus 52.3 Ϯ 12.2 years; P ϭ 0.035), but did not differ by the percentage of males (8.2% versus 9.0%; P ϭ 0.732), percentage of non-Hispanic whites (86.8% versus 85.9%; P ϭ 0.770), or education level (mean Ϯ SD 14.2 Ϯ 2.1 versus 14.3 Ϯ 2.2 years; P ϭ 0.517).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataPatients who satisfy the ACR classification criteria can be identified with an acceptable rate of error by the use of the WPI alone, and with very slightly better results if muscle tenderness or muscle pain is assessed.
“Overall, these data show that patients who satisfy the ACR classification criteria can be identified with an acceptable rate of error by the use of the WPI alone, and with very slightly better results if muscle tenderness or muscle pain is assessed.”
Quote in the paperSubstantial claim- Rests on an assumption: The ACR 1990 classification criteria are a valid reference standard for identifying fibromyalgia cases.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe study sponsor placed no restrictions, offered no input or guidance on the conduct of the study, did not participate in the design of the study, see the results of the study, or review the manuscript or submitted abstracts prior to submission.
“The study sponsor placed no restrictions, offered no input or guidance on the conduct of the study, did not participate in the design of the study, see the results of the study, or review the manuscript or submitted abstracts prior to the submission of the paper.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe ACR classification criteria, rightly criticized for circularity, created a de facto case definition by imposing the 11 tender point rules on top of a crude definition of widespread pain.
“The ACR classification criteria, rightly criticized for circularity (16), created a de facto case definition by imposing the 11 tender point rules on top of a crude definition of widespread pain (17).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [16] 16. Cohen ML, Quintner JL. Fibromyalgia syndrome, a problem of tautology. Lancet 1993;342:906 -9. source
- cites [17] 17. Macfarlane GJ, Croft PR, Schollum J, Silman AJ. Widespread pain: is an improved classification possible? J Rheumatol 1996;23:1628 -32.
May combine two claims.
Interpretationown dataThe SS scale appropriately follows the definitions of ACR classification criteria-positive fibromyalgia, prior fibromyalgia, and non-fibromyalgia, suggesting that it can categorize fibromyalgia symptom severity.
“As shown in Figure 3, the SS scale appropriately follows the definitions of ACR classification criteria-positive fibromyalgia, prior fibromyalgia, and non-fibromyalgia, suggesting that it can categorize fibromyalgia symptom severity.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe ACR classification criteria are unable to provide a useful classification for the 25% of fibromyalgia cases identified as prior fibromyalgia, something that can be somewhat ameliorated through the use of the SS scale.
“However, it is clear that the ACR classification criteria are unable to provide a useful classification for the 25% of fibromyalgia cases we identified as prior fibromyalgia, something that can be somewhat ameliorated through the use of the SS scale.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe diagnostic criteria and SS scale proposed shift the fibromyalgia definition somewhat toward important symptoms: the criteria can be satisfied by a high level of symptoms if the WPI score is not high enough, and fibromyalgia symptoms are accorded appropriate importance by the provision of the SS scale.
“The diagnostic criteria and SS scale we have proposed shift the fibromyalgia definition somewhat toward important symptoms: first, the criteria can be satisfied by a high level of symptoms if the WPI score is not high enough; second, fibromyalgia symptoms are accorded appropriate importance by the provision of the SS scale.”
Quote in the paperSubstantial claim- Rests on an assumption: The case definition of fibromyalgia has changed somewhat with increasing recognition of the importance of cognitive problems and somatic symptoms, factors that were not even considered in the 1990 ACR classification criteria.
May combine two claims.
InterpretationreasoningFibromyalgia differs from rheumatoid arthritis or systemic lupus erythematosus, illnesses that do not involve diagnosis based on symptom severity, where patients continue to have their condition even though they may subsequently not meet diagnostic criteria.
“In this respect, fibromyalgia differs from rheumatoid arthritis or systemic lupus erythematosus, illnesses that do not involve diagnosis based on symptom severity, where patients continue to have their condition even though they may subsequently not meet diagnostic criteria.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The ACR 1990 classification criteria are a valid reference standard for identifying fibromyalgia cases.
“correctly classifies 88.1% of cases classified by the ACR classification criteria”
The paper relies on this without support.
Physician diagnosis of fibromyalgia is a valid way to identify fibromyalgia patients for the study.
“We required the fibromyalgia study patients to have a previous diagnosis of fibromyalgia.”
The paper relies on this without support.
The study sample of rheumatology patients and physicians is representative of primary and specialty care settings where the criteria are intended to be used.
“We recruited study physicians by selecting randomly from a list of 113 rheumatologists who were members of the ACR and who indicated an interest in participating in the study after an e-mail solicitation.”
The paper relies on this without support.
The ACR classification criteria have not been widely embraced in primary care.
“However, they have not been widely embraced in primary care.”
The paper relies on this without support.
The clinical diagnosis in primary care does not ordinarily involve a tender point count or an adequately executed tender count when performed.
“First, the clinical diagnosis in primary care does not ordinarily involve a tender point count or an adequately executed tender count when performed.”
The paper relies on this without support.
The case definition of fibromyalgia has changed somewhat with increasing recognition of the importance of cognitive problems and somatic symptoms, factors that were not even considered in the 1990 ACR classification criteria.
“Second, the case definition of fibromyalgia has changed somewhat with increasing recognition of the importance of cognitive problems and somatic symptoms, factors that were not even considered in the 1990 ACR classification criteria.”
The paper relies on this without support.
The central problem in fibromyalgia criteria is the absence of a gold standard or case definition.
“The central problem in fibromyalgia criteria is the absence of a gold standard or case definition.”
The paper relies on this without support.
The shift in the conceptualization of fibromyalgia that occurred in the clinic and in research studies provided no clear case definition.
“The shift in the conceptualization of fibromyalgia that occurred in the clinic and in research studies, however, provided no clear case definition.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The Symptom Severity Scale is a widely used two-part measure of fibromyalgia-related symptoms.
“The Symptom Severity Scale (SS) is a widely-used, two-part instrument that enables assessment of fibromyalgia-related symptoms over the past week.20”
From Mindfulness is associated with psychological health and moderates the impact of fibromyalgia (2019) · cites this paper as [20]
Table 4 (Discussion; page unavailable) describes two scoring parts: severity ratings for three symptoms over the past week, plus a rating of somatic symptoms in general. The paper establishes the SS scale as a measure of fibromyalgia symptom severity, but presents it as newly created and does not establish that it is widely used. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe American College of Rheumatology (ACR) defines fibromyalgia (FM) as a common chronic illness of unknown aetiology characterised by widespread musculoskeletal pain of more than three months, with generalised sensitivity, pain and tenderness in specific regions.
“The American College of Rheumatology (ACR) defines fibromyalgia (FM) as a common chronic illness of unknown aetiology characterised by widespread musculoskeletal pain of more than three months, with the presence of generalised sensitivity, pain and tenderness in specific regions.”
From Identifying mindfulness and acceptance as mediators between negative affect, functional disability and emotional distress in patients with fibromyalgia (2021) · cites this paper as [5]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredFM is considered an unresolvable primary chronic pain condition wherein evaluations of affective pain appear to be more susceptible to change after intervention than general evaluations of pain that include permanent sensory symptoms.
“FM is considered an unresolvable primary chronic pain condition wherein evaluations of affective pain appear to be more susceptible to change after intervention than general evaluations of pain that include permanent sensory symptoms (Clauw, 2015, Wolfe et al., 1990, Wolfe et al., 2010).”
From Online ACT intervention for fibromyalgia: An exploratory study of feasibility and preliminary effectiveness with smartphone-delivered experiential sampling assessment (2022) · cites this paper as Wolfe et al., 2010
The Discussion (page unavailable) describes fibromyalgia in terms of chronic widespread pain lasting at least three months, supporting the chronic-pain portion. It does not say the condition is unresolvable or compare changes in affective and general pain evaluations after intervention; the Discussion instead acknowledges that painful regions can improve. (LLM, conf=0.87)
Experimental — accuracy not yet measuredThe majority of the included trials applied the ACR 1990 diagnostic criteria which are favorably disposed towards women.
“The majority of the included trials applied the ACR 1990 diagnostic criteria which are favorably disposed towards women [27].”
From Mindfulness- And acceptance-based interventions for patients with fibromyalgia - A systematic review and meta-analyses (2019) · cites this paper as [27]
The Discussion (page unavailable) says the ACR 1990 criteria were useful for providing homogeneity in clinical trials, supporting their relevance to trial selection. It does not establish that a majority of the citing paper’s included trials used them or that the criteria favor women; the Demographics section reports sex proportions but does not assess sex bias. (LLM, conf=0.78)
Experimental — accuracy not yet measuredDiagnoses were self-reported and previously confirmed by a rheumatologist according to ACR 2010 criteria; for online recruits, self-reporting relied solely on patient affirmation.
“Diagnoses were self‐reported and previously confirmed by a rheumatologist, according to the American College of Rheumatology (ACR) 2010 criteria (Wolfe et al. 2010); however, for online recruits, self‐reporting relied solely on patient affirmation.”
From Physical and Mental Health of Fibromyalgia Patients Following October 7th Attack and the Ensuing Military Conflict: A Cross-Sectional Analysis (2025) · cites this paper as Wolfe et al. 2010
Fibromyalgia is a chronic pain syndrome characterized by physical symptoms such as fatigue, stiffness or insomnia, and psychological alterations such as anxiety or depression, that limits the life of people suffering from it.
“Fibromyalgia (FM) is a chronic pain syndrome characterized by physical symptoms like fatigue, stiffness or insomnia, and psychological alterations such as anxiety or depression (de la Coba et al., 2020; Wolfe et al., 1990, Wolfe et al., 2010) that limits the life of people suffering from it.”
From Online ACT intervention for fibromyalgia: An exploratory study of feasibility and preliminary effectiveness with smartphone-delivered experiential sampling assessment (2022) · cites this paper as Wolfe et al., 2010
Diagnostic criteria were determined based on the American College of Rheumatology preliminary diagnostic criteria for FMS.
“Diagnostic criteria were determined based on the American College of Rheumatology preliminary diagnostic criteria for FMS 52 , and participants provided results of a blood test completed within a year to confirm a normal complete blood count and inflammatory panel”
From Stanford Hypnosis Integrated with Functional Connectivity-targeted Transcranial Stimulation (SHIFT): a preregistered randomized controlled trial (2024) · cites this paper as [52]
In men with FMS, patients with pathological skin innervation (distal, proximal, or generalized IENFD reduction) had a higher WPI than patients with normal skin innervation (P < 0.01).
“Patients with FMS and pathological skin innervation (only distal, only proximal, and generalized reduction of IENFD) had a higher clinical Widespread Pain Index (WPI)53 compared with patients with normal skin innervation (P < 0.01; Fig. 4A).”
From Pain and small fiber pathology in men with fibromyalgia syndrome (2024) · cites this paper as [53]
The definition of PPPD paralleled work in other areas of medicine where functional disorders were defined by their core physical symptoms and not associated psychological features.
“The definition of PPPD paralleled work in other areas of medicine where functional disorders (e.g., the functional gastrointestinal disorders [25, 91] and fibromyalgia [93, 94]) were defined by their core physical symptoms and not associated psychological features.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Control-group percentage does not match its count
MinorThe reported 251 controls are 48.8% of the 514 phase 1 subjects, not 48.1%.
Reported 48.1 · recomputed 48.832685
“251 patients (48.1%) who were neither current nor prior fibromyalgia patients (control subjects)”
Table 5 omits the pain-index requirement from one diagnostic branch
MinorTable 5 labels SS ≥9 alone as sufficient in its second branch, while Table 4 also requires WPI 3-6. The Table 5 expression would include patients with WPI below 3 whom the stated criteria exclude.
“ACR 1990 classification criteria vs. diagnostic criteria ((WPI Ն7 AND SS Ն5) OR SS Ն9) 88.1 82.6 95.2 90.8”
“1) Widespread pain index (WPI) Ն7 and symptom severity (SS) scale score Ն5 or WPI 3-6 and SS scale score Ն9.”
Seven categorical patient scales are claimed but six are listed
MinorThe methods say patients completed seven categorical symptom scales, but the ensuing list names only six.
“Patients completed 7 categorical scales for symptoms over the past week”
“Symptoms were assessed using the following words: pain, fatigue, trouble with sleep, trouble with anxiety or depression, problems awaking unrefreshed, and overall severity of your arthritis or fibromyalgia problem.”
Patient symptom-count ranges differ
MinorThe methods define the patient somatic-symptom count as ranging from 0 to 56, but Table 1 labels the patient symptom count as ranging from 0 to 48.
“Patient symptom count (0-48) 22.9 Ϯ 8.8 18.2 Ϯ 8.4 9.7 Ϯ 8.4”
“We summed the positive replies to create a 0 -56 count of somatic symptoms scale.”
Cites
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563 · see citing works
Self-citationData Mining and Knowledge Discovery Handbook
(2010) · doi:10.1007/978-0-387-09823-4 · Cited by 2,190 · see citing works
An Introduction to Recursive Partitioning Using the RPART Routines
Therneau, T. M., & Atkinson, E. J. (2015) · Cited by 1,006 · see citing works
Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls
Yunus, M., Masi, A. T., Calabro, J. J., Miller, K. A., & Feigenbaum, S. L. (1981) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(81)90096-2 · Cited by 910 · see citing works
Self-citationMease, P. J. (2005) · PubMed · Cited by 528 · see citing works
Self-citationWolfe, F., Michaud, K. D., & Pincus, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20549 · Cited by 277 · see citing works
Self-citationFibromyalgia Syndrome Module at OMERACT 9: Domain Construct
MEASE, P., ARNOLD, L. M., CHOY, E. H., CLAUW, D. J., CROFFORD, L. J., GLASS, J. M., MARTIN, S. A., MOREA, J., SIMON, L., STRAND, C. V., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090367 · Cited by 256 · see citing works
Self-citationWolfe, F. (2003) · PubMed · Cited by 172 · see citing works
Self-citationInaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals
Fitzcharles, M.-A. (2003) · Rheumatology · doi:10.1093/rheumatology/keg075 · Cited by 153 · see citing works
Self-citation(1996) · PubMed · Cited by 138 · see citing works
Fibromyalgia syndrome, a problem of tautology
Cohen, M. L., & Quintner, J. L. (1993) · The Lancet · doi:10.1016/0140-6736(93)91950-q · Cited by 138 · see citing works
Moldofsky, H. (2008) · Joint Bone Spine · doi:10.1016/j.jbspin.2008.01.021 · Cited by 126 · see citing works
Crofford, L. J., & Clauw, D. J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10217 · Cited by 109 · see citing works
Self-citation(2007) · PubMed · Cited by 88 · see citing works
Self-citationCHOY, E. H., ARNOLD, L. M., CLAUW, D. J., CROFFORD, L. J., GLASS, J. M., SIMON, L. S., MARTIN, S. A., STRAND, C. V., WILLIAMS, D. A., & MEASE, P. J. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090368 · Cited by 76 · see citing works
Self-citationAwareness of diagnostic and clinical features of fibromyalgia among family physicians
Buskila, D. (1997) · Family Practice · doi:10.1093/fampra/14.3.238 · Cited by 61 · see citing works
Macfarlane, G. J., Jones, G. T., Knekt, P., Aromaa, A., McBeth, J., Mikkelsson, M., & Heliovaara, M. (2007) · Rheumatology · doi:10.1093/rheumatology/kel403 · Cited by 59 · see citing works
Hieblinger, R., Coenen, M., Stucki, G., Winkelmann, A., & Cieza, A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2696 · Cited by 57 · see citing works
Wolfe, F. (1991) · Steinkopff eBooks · doi:10.1007/978-3-642-86812-2_2 · Cited by 54 · see citing works
Self-citationMacfarlane, G. J., Pye, S. R., Finn, J. D., Wu, F. C. W., Silman, A. J., Bartfai, G., Boonen, S., Casanueva, F., Forti, G., Giwercman, A., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089417 · Cited by 46 · see citing works
Wolfe, F., & Michaud, K. D. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080897 · Cited by 39 · see citing works
Self-citationWolfe, F. (1994) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00059-4 · Cited by 30 · see citing works
Self-citationMacfarlane, G. J. (2005) · Current Rheumatology Reports · doi:10.1007/s11926-005-0017-8 · Cited by 14 · see citing works
Data Mining Within a Regression Framework
Berk, R. A. (2004) · eScholarship (California Digital Library) · Cited by 14 · see citing works
Data Mining within a Regression Framework
Berk, R. A. (2006) · Springer eBooks · doi:10.1007/0-387-25465-x_11 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria
Wolfe, F., Clauw, D. J., Fitzcharles, M.-A., Goldenberg, D. L., Häuser, W., Katz, R. L., Mease, P. J., Russell, A. S., Russell, I. J., & Walitt, B. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.08.012 · Cited by 2,232 · see citing works
Self-citationFibromyalgia: A Clinical Review
Clauw, D. J. (2014) · JAMA · doi:10.1001/jama.2014.3266 · Cited by 1,674 · see citing works
Self-citationWOLFE, F., CLAUW, D. J., FITZCHARLES, M.-A., GOLDENBERG, D. L., HÄUSER, W., KATZ, R. S., MEASE, P., RUSSELL, A. S., RUSSELL, I. J., & WINFIELD, J. B. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100594 · Cited by 1,499 · see citing works
Self-citationPrevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies
Fayaz, A., Croft, P., Langford, R. M., Donaldson, L. J., & Jones, G. T. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010364 · Cited by 1,355 · see citing works
Staab, J. P., Eckhardt-Henn, A., Horii, A., Jacob, R., Strupp, M., Brandt, T., & Bronstein, A. (2017) · Journal of Vestibular Research · doi:10.3233/ves-170622 · Cited by 840 · see citing works
Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
Sarzi‐Puttini, P., Giorgi, V., Marotto, D., & Atzeni, F. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00506-w · Cited by 837 · see citing works
Worldwide epidemiology of fibromyalgia
Queiroz, L. P. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0356-5 · Cited by 826 · see citing works
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 729 · see citing works
Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update
Siracusa, R., Paola, R. D., Cuzzocrea, S., & Impellizzeri, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083891 · Cited by 710 · see citing works
Overlapping Chronic Pain Conditions: Implications for Diagnosis and Classification
Maixner, W., Fillingim, R. B., Williams, D. A., Smith, S. B., & Slade, G. D. (2016) · The Journal of Pain · doi:10.1016/j.jpain.2016.06.002 · Cited by 558 · see citing works
Distinctions between diagnostic and classification criteria?
Aggarwal, R., Ringold, S., Khanna, D., Neogi, T., Johnson, S. R., Miller, A., Brunner, H. I., Ogawa, R., Felson, D., Ogdie, A., et al. (2015) · Arthritis Care & Research · doi:10.1002/acr.22583 · Cited by 539 · see citing works
Psychological factors associated with development of TMD: the OPPERA prospective cohort study
Fillingim, R. B., Ohrbach, R., Greenspan, J. D., Knott, C., Diatchenko, L., Dubner, R., Bair, E., Baraian, C., Mack, N., Slade, G. D., et al. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2013.06.009 · Cited by 528 · see citing works
Häuser, W., Ablin, J., Fitzcharles, M.-A., Littlejohn, G., Luciano, J. V., Usui, C., & Walitt, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.22 · Cited by 505 · see citing works
Self-citationThe Epidemiology and Economic Consequences of Pain
Henschke, N., Kamper, S. J., & Maher, C. G. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.09.010 · Cited by 502 · see citing works
Jones, G. T., Atzeni, F., Beasley, M., Flüß, E., Sarzi‐Puttini, P., & Macfarlane, G. J. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38905 · Cited by 468 · see citing works
Prevalence of fibromyalgia: literature review update
Marques, A. P., Santo, A. D. S. D. E., Assumpção, A. L. B. N. M., Matsutani, L. A., & Yuan, S. L. K. (2017) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/j.rbre.2017.01.005 · Cited by 448 · see citing works
Wolfe, F., Brähler, E., Hinz, A., & Häuser, W. (2013) · Arthritis Care & Research · doi:10.1002/acr.21931 · Cited by 443 · see citing works
Self-citationAAPT Diagnostic Criteria for Fibromyalgia
Arnold, L. M., Bennett, R. M., Crofford, L. J., Dean, L. E., Clauw, D. J., Goldenberg, D. L., Fitzcharles, M., Paiva, E. S., Staud, R. M., Sarzi‐Puttini, P., et al. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.10.008 · Cited by 437 · see citing works
Self-citationFitzcharles, M.-A., Ste-Marie, P. A., Goldenberg, D. L., Pereira, J. X., Abbey, S., Choinière, M., Ko, G., Moulin, D. E., Panopalis, P., Proulx, J., et al. (2013) · Pain Research and Management · doi:10.1155/2013/918216 · Cited by 409 · see citing works
Self-citationThe neurobiology of central sensitization
Harte, S. E., Harris, R. E., & Clauw, D. J. (2018) · Journal of Applied Biobehavioral Research · doi:10.1111/jabr.12137 · Cited by 404 · see citing works
Self-citationMansfield, K. E., Sim, J., Jordan, J. L., & Jordan, K. P. (2016) · Pain · doi:10.1097/j.pain.0000000000000314 · Cited by 402 · see citing works
Antiepileptic drugs for neuropathic pain and fibromyalgia
Wiffen, P. J., Derry, S., Moore, R. A., Aldington, D. J., Cole, P., Rice, A. S. C., Lunn, M. P., Hamunen, K., Haanpää, M. L., & Kalso, E. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010567.pub2 · Cited by 395 · see citing works
Fibromyalgia Syndrome: Etiology, Pathogenesis, Diagnosis, and Treatment
Bellato, E., Marini, E., Castoldi, F., Barbasetti, N., Mattei, L., Bonasia, D. E., & Blonna, D. (2012) · Pain Research and Treatment · doi:10.1155/2012/426130 · Cited by 389 · see citing works
Vincent, A., Lahr, B. D., Wolfe, F., Clauw, D. J., Whipple, M. O., Oh, T. H., Barton, D. L., & Sauver, J. L. S. (2012) · Arthritis Care & Research · doi:10.1002/acr.21896 · Cited by 385 · see citing works
Self-citationPsychological impact of fibromyalgia: current perspectives
Galvez-Sánchez, C. M., Duschek, S., & del Paso, G. A. R. (2019) · Psychology Research and Behavior Management · doi:10.2147/prbm.s178240 · Cited by 366 · see citing works
miRNA: A Promising Therapeutic Target in Cancer
Menon, A., Abd-Aziz, N., Khalid, K., Poh, C. L., & Naidu, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911502 · Cited by 361 · see citing works
Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias
Wolfe, F., Walitt, B., Perrot, S., Rasker, J. J., & Häuser, W. (2018) · PLOS ONE · doi:10.1371/journal.pone.0203755 · Cited by 346 · see citing works
Self-citationManagement of functional somatic syndromes and bodily distress
Henningsen, P., Zipfel, S., Sattel, H., & Creed, F. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000484413 · Cited by 335 · see citing works
Aerobic exercise training for adults with fibromyalgia
Bidonde, J., Busch, A. J., Schachter, C. L., Overend, T. J., Kim, S. Y., Góes, S. M., Boden, C., & Foulds, H. J. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012700 · Cited by 334 · see citing works
Resistance exercise training for fibromyalgia
Busch, A. J., Webber, S. C., Richards, R. S., Bidonde, J., Schachter, C. L., Schafer, L. A., Danyliw, A., Sawant, A., Dal Bello-Haas, V., Rader, T., et al. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010884 · Cited by 333 · see citing works
Exercise therapy for fibromyalgia
Busch, A. J., Webber, S. C., Brachaniec, M., Bidonde, J., Bello-Haas, V. D., Danyliw, A. D., Overend, T. J., Richards, R. S., Sawant, A., & Schachter, C. L. (2011) · Current Pain and Headache Reports · doi:10.1007/s11916-011-0214-2 · Cited by 333 · see citing works
The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey
Walitt, B., Nahin, R., Katz, R., Bergman, M., & Wolfe, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138024 · Cited by 274 · see citing works
Self-citationBair, M. J., & Krebs, E. E. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202003030 · Cited by 320 · see citing works
van de Donk, T., Niesters, M., Kowal, M. A., Olofsen, E., Dahan, A., & van Velzen, M. (2018) · Pain · doi:10.1097/j.pain.0000000000001464 · Cited by 317 · see citing works
Clauw, D. J., Arnold, L. M., & McCarberg, B. H. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0206 · Cited by 314 · see citing works
Self-citationOaklander, A. L., Herzog, Z. D., Downs, H. M., & Klein, M. M. (2013) · Pain · doi:10.1016/j.pain.2013.06.001 · Cited by 312 · see citing works
A prevalência de fibromialgia: atualização da revisão de literatura
Marques, A. P., Santo, A. D. S. D. E., Berssaneti, A. A., Matsutani, L. A., & Yuan, S. L. K. (2017) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2016.10.004 · Cited by 302 · see citing works
Fibromyalgia Pathogenesis and Treatment Options Update
Chinn, S. B., Caldwell, W., & Gritsenko, K. (2016) · Current Pain and Headache Reports · doi:10.1007/s11916-016-0556-x · Cited by 301 · see citing works
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & Rice, A. S. C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub3 · Cited by 297 · see citing works
Häuser, W., Petzke, F. W., Üçeyler, N., & Sommer, C. (2010) · Rheumatology · doi:10.1093/rheumatology/keq354 · Cited by 289 · see citing works
Wang, C., Schmid, C. H., Fielding, R. A., Harvey, W. F., Reid, K. F., Price, L. L., Driban, J. B., Kalish, R., Rones, R., & McAlindon, T. (2018) · BMJ · doi:10.1136/bmj.k851 · Cited by 285 · see citing works
Fibromyalgia: A Critical and Comprehensive Review
Borchers, A. T., & Gershwin, M. E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8509-4 · Cited by 279 · see citing works
Passive transfer of fibromyalgia symptoms from patients to mice
Goebel, A., Krock, E., Gentry, C., Israel, M. R., Jurczak, A., Urbina, C. M., Sandor, K., Vastani, N., Maurer, M., Cuhadar, U., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144201 · Cited by 278 · see citing works
Cognitive behavioural therapies for fibromyalgia
Bernardy, K., Klose, P., Busch, A. J., Choy, E. H., & Häuser, W. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009796.pub2 · Cited by 272 · see citing works
Lauche, R., Cramer, H., Dobos, G., Langhorst, J., & Schmidt, S. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.10.010 · Cited by 268 · see citing works
Fibromyalgia and related conditions
Clauw, D. J. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.03.014 · Cited by 259 · see citing works
Self-citationAcupuncture for treating fibromyalgia
Deare, J. C., Zheng, Z., Xue, C. C., Liu, J., Shang, J., Scott, S., & Littlejohn, G. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007070.pub2 · Cited by 256 · see citing works
Evidence for central sensitization in chronic whiplash: A systematic literature review
Oosterwijck, J. V., Nijs, J., Meeus, M., & Paul, L. (2012) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00193.x · Cited by 255 · see citing works
Fillingim, R. B. (2017) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-803506-1.00038-3 · Cited by 255 · see citing works
Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults
Gill, D., Derry, S., Wiffen, P. J., & Moore, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009183.pub2 · Cited by 253 · see citing works
Aquatic exercise training for fibromyalgia
Bidonde, J., Busch, A. J., Webber, S. C., Schachter, C. L., Danyliw, A. D., Overend, T. J., Richards, R. S., & Rader, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011336 · Cited by 252 · see citing works
Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives
Galvez-Sánchez, C. M., & Reyes del Paso, G. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041219 · Cited by 241 · see citing works
Walking Exercise for Chronic Musculoskeletal Pain: Systematic Review and Meta-Analysis
O'Connor, S. R., Tully, M. A., Ryan, B., Bleakley, C. M., Baxter, G. D., Bradley, J. M., & McDonough, S. M. (2015) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2014.12.003 · Cited by 234 · see citing works
Fibromialgia: prevalencia, perfiles epidemiológicos y costes económicos
Cabo-Meseguer, A., Cerdá-Olmedo, G., & Trillo-Mata, J. L. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.06.008 · Cited by 231 · see citing works
Fibromyalgia: from pathophysiology to therapy
Schmidt‐Wilcke, T., & Clauw, D. J. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.98 · Cited by 231 · see citing works
Self-citationFacts and myths pertaining to fibromyalgia
Häuser, W., & Fitzcharles, M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.1/whauser · Cited by 229 · see citing works
Self-citationImproving the Recognition and Diagnosis of Fibromyalgia
Arnold, L. M., Clauw, D. J., & McCarberg, B. H. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0738 · Cited by 226 · see citing works
Self-citationBranco, J., Rodrigues, A. M., Gouveia, N., Eusébio, M., Ramiro, S., Machado, P., da Costa, L. P., Mourão, A. F., da Silva, I. P., Laires, P. A., et al. (2016) · RMD Open · doi:10.1136/rmdopen-2015-000166 · Cited by 226 · see citing works
Nüesch, E., Häuser, W., Bernardy, K., Barth, J., & Jüni, P. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201249 · Cited by 225 · see citing works
O’Brien, A. T., Deitos, A., Pego, Y. T., Fregni, F., & Carrillo‐de‐la‐Peña, M. T. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.01.010 · Cited by 225 · see citing works
Milnacipran for neuropathic pain and fibromyalgia in adults
Derry, S., Gill, D., Phillips, T., & Moore, R. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008244.pub2 · Cited by 224 · see citing works
Wijma, A. J., van Wilgen, C. P., Meeus, M., & Nijs, J. (2016) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2016.1194651 · Cited by 222 · see citing works
The prevalence of severe fatigue in rheumatic diseases: an international study
Overman, C. L., Kool, M. B., da Silva, J. A. P., & Geenen, R. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-3035-6 · Cited by 218 · see citing works
Bernardy, K., Klose, P., Welsch, P., & Häuser, W. (2018) · European Journal of Pain · doi:10.1002/ejp.1121 · Cited by 217 · see citing works
Grayston, R., Czanner, G., Elhadd, K., Goebel, A., Frank, B., Üçeyler, N., Malik, R. A., & Alam, U. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2018.08.003 · Cited by 213 · see citing works
Van Oosterwijck, J., Meeus, M., Paul, L., De Schryver, M., Pascal, A., Lambrecht, L., & Nijs, J. (2013) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31827c7a7d · Cited by 212 · see citing works
Disrupted Functional Connectivity of the Pain Network in Fibromyalgia
Cifré, I., Sitges, C., Fraiman, D., Muñoz, M. Á., Balenzuela, P., González‐Roldán, A. M., Martínez-Jauand, M., Birbaumer, N., Chialvo, D. R., & Montoya, P. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182408f04 · Cited by 212 · see citing works
Brummett, C. M., Janda, A. M., Schueller, C. M., Tsodikov, A. D., Morris, M., Williams, D. A., & Clauw, D. J. (2013) · Anesthesiology · doi:10.1097/aln.0b013e3182a8eb1f · Cited by 210 · see citing works
Self-citationPain management in the Ehlers–Danlos syndromes
Chopra, P., Tinkle, B., Hamonet, C., Brock, I., Gompel, A., Bulbena, A., & Francomano, C. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31554 · Cited by 209 · see citing works
Younger, J., Noor, N., McCue, R., & Mackey, S. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37734 · Cited by 209 · see citing works
D’Agnelli, S., Arendt‐Nielsen, L., Gerra, M. C., Zatorri, K., Boggiani, L., Baciarello, M., & Bignami, E. G. (2018) · Molecular Pain · doi:10.1177/1744806918819944 · Cited by 209 · see citing works
Kleykamp, B. A., Ferguson, M. C., McNicol, E., Bixho, I., Arnold, L. M., Edwards, R. R., Fillingim, R., Grol-Prokopczyk, H., Turk, D. C., & Dworkin, R. H. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.10.006 · Cited by 202 · see citing works
One year in review 2021: fibromyalgia
Alciati, A., Nucera, V., Masala, I. F., Giallanza, M., Corte, L. L., Giorgi, V., Sarzi‐Puttini, P., & Atzeni, F. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/gz4i3i · Cited by 200 · see citing works
The Role of Antidepressants in the Management of Fibromyalgia Syndrome
Häuser, W., Wolfe, F., Tölle, T. R., Üçeyler, N., & Sommer, C. (2012) · CNS Drugs · doi:10.2165/11598970-000000000-00000 · Cited by 199 · see citing works
Self-citationClos‐Garcia, M., Andrés, N., Fernández‐Eulate, G., Abecia, L., Lavín, J. L., Liempd, S. M. V., Cabrera, D., Royo, F., Valero, A., Errazquin, N., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.031 · Cited by 198 · see citing works
Fibromyalgia: An Afferent Processing Disorder Leading to a Complex Pain Generalized Syndrome
Smith, H. S. (2011) · Pain Physician · doi:10.36076/ppj.2011/14/e217 · Cited by 198 · see citing works
Wang, X., Walitt, B. T., Saligan, L. N., Tiwari, A., Cheung, C. W., & Zhang, Z.-J. (2015) · Cytokine · doi:10.1016/j.cyto.2014.12.006 · Cited by 196 · see citing works
Brummett, C. M., Urquhart, A. G., Hassett, A. L., Tsodikov, A., Hallstrom, B. R., Wood, N. I., Williams, D. A., & Clauw, D. J. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39051 · Cited by 195 · see citing works
Self-citationVillamar, M. F., Wivatvongvana, P., Patumanond, J., Bikson, M., Truong, D. Q., Datta, A., & Fregni, F. (2013) · Journal of Pain · doi:10.1016/j.jpain.2012.12.007 · Cited by 194 · see citing works
Langhorst, J., Klose, P., Dobos, G. J., Bernardy, K., & Häuser, W. (2012) · Rheumatology International · doi:10.1007/s00296-012-2360-1 · Cited by 193 · see citing works
Spiritual Needs of Patients with Chronic Diseases
Büssing, A., & Koenig, H. G. (2010) · Religions · doi:10.3390/rel1010018 · Cited by 192 · see citing works
Carbamazepine for chronic neuropathic pain and fibromyalgia in adults
Wiffen, P. J., Derry, S., Moore, A., & Kalso, E. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005451.pub3 · Cited by 190 · see citing works
Glass, J. M., Williams, D. A., Fernandez-Sanchez, M.-L., Kairys, A. E., Barjola, P., Heitzeg, M. M., Clauw, D. J., & Schmidt‐Wilcke, T. (2011) · Journal of Pain · doi:10.1016/j.jpain.2011.06.007 · Cited by 188 · see citing works
Self-citationPatterns of multisite pain and associations with risk factors
Coggon, D., Ntani, G., Palmer, K. T., Felli, V. E. A., Harari, R., Barrero, L. H., Felknor, S. A., Gimeno, D., Cattrell, A., Vargas-Prada, S., et al. (2013) · Pain · doi:10.1016/j.pain.2013.05.039 · Cited by 187 · see citing works
Sun, Y., Laksono, I., Selvanathan, J., Saripella, A., Nagappa, M., Pham, C., Englesakis, M. F., Peng, P., Morin, C. M., & Chung, F. F. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101467 · Cited by 186 · see citing works
Acute and training effects of resistance exercise on heart rate variability
Kingsley, J. D., & Figueroa, A. (2014) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12223 · Cited by 184 · see citing works
Luciano, J. V., Guallar, J. A., Aguado, J., López-del-Hoyo, Y., Olivan, B., Magallón, R., Alda, M., Serrano-Blanco, A., Gili, M., & Garcia-Campayo, J. (2014) · PAIN · doi:10.1016/j.pain.2013.12.029 · Cited by 183 · see citing works
Häuser, W., Galek, A., Erbslöh-Möller, B., Köllner, V., Kühn-Becker, H., Langhorst, J., Petermann, F., Prothmann, U., Winkelmann, A., Schmutzer, G., et al. (2013) · Pain · doi:10.1016/j.pain.2013.03.034 · Cited by 180 · see citing works
Phenotypic features of central sensitization
Williams, D. A. (2018) · Journal of Applied Biobehavioral Research · doi:10.1111/jabr.12135 · Cited by 180 · see citing works
Fibromyalgia diagnosis and diagnostic criteria
Wolfe, F., & Häuser, W. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.595734 · Cited by 178 · see citing works
Self-citationDisrupted Brain Circuitry for Pain‐Related Reward/Punishment in Fibromyalgia
Loggia, M. L., Berna, C., Kim, J., Cahalan, C. M., Gollub, R. L., Wasan, A. D., Harris, R. E., Edwards, R. R., & Napadow, V. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38191 · Cited by 178 · see citing works
Nijs, J., Roussel, N. A., Oosterwijck, J. V., Kooning, M. D., Ickmans, K., Struyf, F., Meeus, M., & Lundberg, M. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2277-4 · Cited by 177 · see citing works
Rodríguez‐Pintó, I., Agmon‐Levin, N., Amital, H., & Shoenfeld, Y. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.01.009 · Cited by 170 · see citing works
Neurogenic inflammation in fibromyalgia
Littlejohn, G. O., & Guymer, E. K. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0672-2 · Cited by 167 · see citing works
IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients
Cabrera, D. M., de la Cruz-Aguilera, D. L., Barrera-Villalpando, M.-I., Becerril‐Villanueva, E., Arreola, R., Hernández-Ferreira, E., Pérez‐Tapia, S. M., Pérez‐Sánchez, G., Garcés-Alvarez, M. E., Aguirre‐Cruz, L., et al. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.11.011 · Cited by 166 · see citing works
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome
Häuser, W., Urrútia, G., Tort, S., Üçeyler, N., & Walitt, B. T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010292 · Cited by 164 · see citing works
Potvin, S., & Marchand, S. (2016) · Pain · doi:10.1097/j.pain.0000000000000573 · Cited by 164 · see citing works
An Association of Serotonin with Pain Disorders and Its Modulation by Estrogens
Paredes, S., Cantillo, S., Candido, K. D., & Knežević, N. N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225729 · Cited by 164 · see citing works
Preliminary validation of the Michigan Body Map
Brummett, C. M., Bakshi, R. R., Goesling, J., Leung, D., Moser, S. E., Zollars, J. W., Williams, D. A., Clauw, D. J., & Hassett, A. L. (2016) · Pain · doi:10.1097/j.pain.0000000000000506 · Cited by 163 · see citing works
Self-citationMeta-analysis of cognitive performance in fibromyalgia
Bell, T. R., Trost, Z., Buelow, M. T., Clay, O. J., Younger, J., Moore, D., & Crowe, M. G. (2018) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2017.1422699 · Cited by 162 · see citing works
- Authors
- Wolfe, F., Clauw, D. J., Fitzcharles, M., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B.
- Affiliations
- University of Kansas (US)
- University of Michigan (US)
- Montreal General Hospital (CA)
- Tufts University (US)
- Rush University Medical Center (US)
- Swedish Medical Center (US)
- University of Alberta (CA)
- The University of Texas at San Antonio Health Science Center (US)
- University of North Carolina at Chapel Hill (US)
- Peoria campus of the University of Illinois System (US)
- ORCID
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2010-04-29
- Volume
- 62
- Issue
- 5
- Pages
- 600-610
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W2049056319
- Cited by
- 3,952
- References
- 25
- Citations by year
- 2026: 159 · 2025: 217 · 2024: 220 · 2023: 233 · 2022: 299 · 2021: 363 · 2020: 287 · 2019: 278 · 2018: 278 · 2017: 262 · 2016: 259 · 2015: 259 · 2014: 237 · 2013: 225 · 2012: 182
- FWCI
- 129.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arthritis Care & Research (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Myofascial pain diagnosis and treatment
- Keywords
- fibromyalgia, diagnostic criteria, symptom severity scale, Widespread Pain Index, case definition, fatigue, sleep disorders, cognitive symptoms, somatic symptoms
- MeSH terms
- Fibromyalgia, Health Status Indicators, Humans, Medical Informatics, Pain, Rheumatology, Sensitivity and Specificity, Severity of Illness Index, Societies, Medical, United States, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-22.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-22.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review